Syngene International (BSE: 539268, NSE: SYNGENE, ISIN: INE398R01022), a leading integrated contract research, development, and manufacturing organisation, announces its participation as an exhibitor at CPHI North America 2024, held at the Pennsylvania Convention Center, Philadelphia, from 7-9 May 2024.

Syngene, renowned for its scientific services spanning from early discovery to commercial supply, will be exhibiting at Stand 1011. Attendees can explore Syngene’s cutting-edge solutions tailored for the pharmaceutical, biotech, nutrition, animal health, consumer goods and speciality chemical industries.

For Small Molecules, Syngene has FDA-approved capabilities ranging from PC to CMC filing. From lab-scale to commercial. These include:

  • Drug Substance Development and Manufacturing
  • Formulation Development and Manufacturing
  • Custom Synthesis of Speciality Materials and Polymers
  • Clinical Trial Management

CPHI North America 2024

Join a global network of pharma professionals by attending pharma’s most innovative event to discover further learning, innovation, and collaboration. As the exclusive pharma event in the Americas covering the end-to-end supply chain, it’s the ONLY place to meet suppliers from all across our industry.

The Syngene team look forward to connecting with you in Philadelphia!